athira pharma stock buy

What was the 52-week low for Athira. Stay up to date on the latest stock price chart news.

Best Erp For Pharmaceutical Industry Pharma Erp Software At Best Price Erp For Pharmaceutical Manufacturers Erp For Pharmaceutical Distributors Increase Pharmaceutical Manufacturing Pharmaceutical Pharmaceutical Industry

Actively observing the price movement in the last trading the stock closed the session at 339 falling within a range of 330 and 361.

. 18706 North Creek Parkway Suite 104. What is ATHAs Earnings Per Share EPS forecast for 2022-2024. ATHA has been upgraded to a Zacks Rank 2 Buy reflecting growing optimism about the companys earnings prospects.

According to 11 analysts the average rating for ATHA stock is Buy The 12-month stock price forecast is 102 which is an increase of 19825 from the latest price. Decide on an online brokerage but dont worry - weve analyzed dozens of online stock brokerages and apps to help you figure out where to buy Athira Pharma stock. Finally Stifel Nicolaus lowered shares of Athira Pharma from a buy rating to a hold rating and dropped their price objective for the stock from 3600 to 500 in a research note on.

A hold rating indicates that analysts believe investors should maintain any existing positions they have in ATHA but not buy additional shares or sell existing shares. Deposit funds into your brokerage account. T 1 425 620-8501.

Athira Pharma will sell 4 million shares of its common stock for 2250 per share. Sign up for a brokerage account. ATHA appears an attractive pick as it has been recently upgraded to a Zacks Rank 2 Buy.

Athira Pharma Incshares have had an EPS of -178. Shares are traded in NMS. Get a real-time Athira Pharma Inc.

30 Days of MarketBeat All Access for 100. Is Athira Pharma Stock a good buy in 2022 according to Wall Street analysts. NASDAQATHA shares rose in value on Wednesday 080322 with the stock price up by 265 to the previous days close as strong demand from buyers drove the stock to 348.

The Companys lead candidate fosgonimeton ATH-1017 is a subcutaneously administered blood brain barrier BBB-penetrating small molecule HGFMET positive modulator. Common Stock ATHA. Athira Pharma stock has received a consensus rating of buy.

Stock price gained 150 on the last trading day Tuesday 2nd Aug 2022 rising from 334 to 339. The bid size displays the total amount of desired shares to buy at that price and the ask size. Sign up for 0 commission trading with the highest-rated brokerage weve.

The consensus among Wall Street research analysts is that investors should hold Athira Pharma stock. The Company is focused on developing small molecules to restore neuronal health and stop neurodegeneration. Over the last year we see that it reached a high of 1665 and a low of 253.

It had closed Wednesdays trading session at. The average Athira Pharma stock price prediction forecasts a potential upside of 37198 from the current ATHA share price of 339. Stock price up 15 on TuesdayUpdated on Aug 02 2022 The Athira Pharma Inc.

Is a clinical-stage biopharmaceutical company. Should I buy Athira Pharma. Likewise its dividend rate has been with a dividend yield of.

That means you want to buy stocks with a Zacks Rank 1 or 2. This rating change essentially reflects an upward trend in earnings estimates. This might drive the.

Athira Pharma Inc. Athira Pharma Inc. View analyst ratings for Athira Pharma or view top-rated stocks.

The average rating score is and is based on 7 buy ratings 2 hold ratings and 0 sell ratings. Top Stocks to Buy in 2022 Stock Market News Premium Services. Athira Pharma Inc.

The price has risen in 6 of the last 10 days and is up. Choose where to buy Athira Pharma stock. Insiders have sold a total of 14767 Athira Pharma shares in the last 24 months for a total of 3972323 sold.

Other Robinhood Financial fees may apply check rbnhdcofees for details. Athira Pharma Inc. That means you want to buy stocks with a Zacks Rank 1 or 2 Strong Buy or Buy which also has a Score of an A or a B in your personal trading style.

You can buy and sell Athira Pharma ATHA and other stocks ETFs and options commission-free on Robinhood with real-time quotes market data and relevant news. You need to. The company is developing treatments for Alzheimers disease and Parkinsons disease.

Athira Pharma Inc. During the day the stock fluctuated 606 from a day low at 330 to a day high of 350. Get the latest Athira Pharma Inc ATHA detailed stock quotes stock data Real-Time ECN charts stats and more.

ATHA stock price quote with breaking news financials statistics charts and more. Get a real-time Athira Pharma Inc. If we look at the share price of Athira Pharma Inc.

A high-level overview of Athira Pharma Inc.

What Kind Of Investors Own Most Of Athira Pharma Inc Nasdaq Atha

Insiders Turn Bullish On Athira Pharma Shares Rise

Why Athira Pharma Stock Dropped Today The Motley Fool

Athira Pharma Inc Atha Stock Price Us04746l1044 Marketscreener

Btig Starts Athira Pharma At Buy Pt 33 Biotuesdays

Stock Photos Royalty Free Images And Vectors Royalty Free Images Stock Photos Stock Images Free

Athira Pharma Stock Forecast Down To 0 000001 Usd Atha Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis

What Kind Of Investors Own Most Of Athira Pharma Inc Nasdaq Atha

Follow Athira Pharma S Athirapharma Latest Tweets Twitter

Athira Pharma Announces Topline Results From Act Ad Phase 2 Proof Of Concept Study Of Fosgonimeton In Mild To Moderate Alzheimer S Disease Athira Pharma

Rapid Micro And Athira Pharma Stock See Action From Activist Investors Barron S

Why Athira Pharma Stock Imploded Today The Motley Fool

Athira Pharma Falls 40 Amid Questions About Ceo S Phd Research Barron S

Stock Quote Chart Athira Pharma

Atha Stock Price And Chart Nasdaq Atha Tradingview

Athira Pharma Stock Forecast Down To 0 000001 Usd Atha Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis